Welcome to the Divis Labs Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.

Divi’s Laboratories share price closed at Rs 3708, up Rs 9 or 0.25%. Divi’s Laboratories share price moved from Rs 3610 to Rs ...

Welcome to the Divis Labs Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a prominent stock. Dive into the current details of Divis Labs, including: Last ...

Get all latest & breaking news on Divis Labs. Watch videos, top stories and articles on Divis Labs at moneycontrol.com.

Earnings call Divi's Laboratories reported Q3 FY26 revenue of ₹2,692 Cr, up 12.1% YoY, with profit before tax (ex-exceptional) rising 17.6% YoY to ₹854 Cr. Gross margin improved significantly due to ...

Divi's Laboratories Ltd (NSE:DIVISLAB) is set to release its Q2 2026 earnings on Nov 7, 2025. The consensus estimate for Q2 2026 revenue is $25.86 billion, and the earnings are expected to come in at ...

HYDERABAD, India--(BUSINESS WIRE)--Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced that Divi’s Laboratories (NSE: DIVISLAB), one of the largest active ...

India, Jan. 15 -- The shares of this pharma stock, engaged in the manufacturing and exporting of API's and Nutraceutical ingredients, are in focus after leading global brokerage, CITI, has expressed ...

Kakinada: In a gesture of corporate support to student welfare, Divi’s Laboratories Limited has donated essential materials ...

Shares of pharmaceutical firm Divis Laboratories hit their record high rising by as much as 4.37% to reach an all-time high of Rs 6,764 per share. As of noon, Divis Laboratories shares were trading at ...

Divi’s Laboratories (DIVI) Q3FY26 EBITDA was 3% above our estimates led by higher CS revenues and currency led tailwinds. We expect margins to improve, led by better product mix and stable raw ...